Dr. Reddy's Laboratories Ltd.
Snapshot View

4260.80 +2.50 ▲0.1%

12 August 2022, 04:11:06 PM
Volume: 404,258

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.drreddys.com
Market Cap 70,944.49 Cr.
Enterprise Value(EV) 71,885.65 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 179.70 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 23.69 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 1,216.52 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.50 Calculated using Price: 4,258.00
Dividend Yield 0.70 Period Ending 2022-03
No. of Shares Subscribed 16.64 Cr. 166,448,444 Shares
FaceValue 5
Company Profile
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.06%
1 Week
+2.50%
1 Month
-4.97%
3 Month
+9.81%
6 Month
-1.49%
1 Year
-9.66%
2 Year
-5.70%
5 Year
+111.86%
10 Year
+159.07%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 27.88 26.63 18.95 10.20 7.40 14.42 13.38 11.53 11.55
Return on Capital Employed (%) 24.77 22.69 19.55 9.77 8.21 13.41 10.81 15.24 14.27
Return on Assets (%) 13.47 13.67 11.05 6.14 4.23 8.66 8.95 8.01 7.82

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 6,369 7,865 9,853 12,570 12,262 12,572 14,024 15,599 17,642 19,212
Non Curr. Liab. 1,285 2,182 1,678 877 456 2,538 2,113 -808 -197 -508
Curr. Liab. 5,659 5,790 6,821 6,347 8,420 6,894 5,897 7,214 8,104 9,766
Minority Int.
Equity & Liab. 13,313 15,838 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470
Non Curr. Assets 4,786 5,512 6,476 8,000 11,454 11,505 10,924 9,406 10,998 10,682
Curr. Assets 8,527 10,326 11,877 11,794 9,684 10,498 11,110 12,599 14,550 17,788
Misc. Exp. not W/O
Total Assets 13,313 15,838 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 13,415 15,023 15,568 14,196 14,281 15,448 17,517 19,048 21,545 21,833
Other Income 170 274 295 172 155 338 621 291 485 1,237
Total Income 13,585 15,297 15,863 14,368 14,436 15,786 18,138 19,339 22,030 23,070
Total Expenditure -10,165 -11,530 -11,983 -11,724 -11,930 -12,270 -15,047 -15,178 -17,778 -17,865
PBIDT 3,421 3,768 3,880 2,644 2,506 3,516 3,091 4,161 4,252 5,205
Interest -127 -108 -83 -63 -79 -89 -98 -97 -96 -111
Depreciation -648 -760 -939 -1,027 -1,077 -1,135 -1,163 -1,229 -1,165 -1,183
Taxation -683 -563 -751 -297 -438 -386 140 -932 -879 -983
Exceptional Items
PAT 1,963 2,336 2,108 1,257 912 1,906 1,970 1,904 2,112 2,928
Minority Interest
Share Associate 23 35 34 44 56 48 70 63
Other Related Items
Consolidated Net Profit 1,963 2,336 2,131 1,292 947 1,950 2,026 1,952 2,183 2,991
Adjusted EPS 115 137 125 78 57 117 122 117 131 180

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,378 1,970 2,524 3,263 2,144 1,803 2,870 2,984 3,570 2,811
Cash Fr. Inv. -1,446 -1,694 -2,265 -2,039 -1,840 -1,488 -773 -492 -2,266 -2,639
Cash Fr. Finan. -157 -24 -433 -1,700 -369 -444 -2,133 -2,516 -30 -242
Net Change -225 251 -174 -477 -65 -129 -35 -24 1,275 -70
Cash & Cash Eqvt 520 862 583 492 378 254 223 196 1,482 1,485

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 26.74 26.74 26.73 26.74 26.73 26.72 26.72 26.72 26.71
Public 59.24 59.16 60.15 61.06 61.18 61.24 61.75 62.05 62.92
Depository Receipts 14.02 14.10 13.12 12.21 12.09 12.05 11.53 11.23 10.37
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 04 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Thu, 04 Aug 2022
General updates
Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Duplicate Share certificate
Wed, 03 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Fri, 12 Aug 2022
Making Higher Highs for 3 days Making Higher Highs for 3 days
High Increase 5 Years High Increase 5 Years
Closing Near 100 SMA Closing Near 100 SMA
Closing Near 20 SMA Closing Near 20 SMA
ROC Trending Up ROC Trending Up

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Abbott India Ltd. 39,867.83 18,761.95 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-06 49.31 18,761.95 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-06 13.37 18,761.95 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 18,761.95 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,761.95 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,761.95 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,761.95 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 18,761.95 -1.0%

FAQ's On Dr. Reddy's Laboratories Ltd.

Can I Buy Dr. Reddy's Lab Shares now?

What is the Share Price of Dr. Reddy's Lab?

What is the Relative Strength Index (RSI) Value of Dr. Reddy's Lab?

What is the Market Capital (MCAP) of Dr. Reddy's Lab?

What are the key metrics to analyse Dr. Reddy's Lab?

What is the Price Performance of Dr. Reddy's Lab?